Last reviewed · How we verify
NCT06102343
Safety and Efficacy Investigation on the Effects of ClearSkin Non-ablative ER:Glass 1540nm Laser Module in the Treatment of Acne Scars.
NA trial testing Alma Harmony in Acne Scars - Mixed Atrophic and Hypertrophic in 41 participants. Status unknown.
1 January 2025
Quick facts
| Lead sponsor | Alma Lasers |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 41 |
| Start date | 1 January 2024 |
| Primary completion | 1 January 2025 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Alma Harmony
Conditions studied
- Acne Scars - Mixed Atrophic and Hypertrophic — all drugs for Acne Scars - Mixed Atrophic and Hypertrophic →
Sponsor
Alma Lasers
Who can join
Adults 18 to 50, any sex, with Acne Scars - Mixed Atrophic and Hypertrophic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The ClearSkin module, Er: Glass 1540nm, is largely used in the treatment of acne vulgaris and acne scars. The non-ablative ER:Glass 1540 nm laser deeply penetrates the skin, causing thermal damage to the sebaceous glands, destroying P. acnes bacteria and reducing sebum production, while leaving the epidermis intact. The integrated vacuum mechanism extracts accumulated sebaceous material from the pores, while contact cooling protects the skin, reducing pain and allowing for safer and more effective treatment of the sebaceous glands within the dermis. Based on this background, the investigators have considered a pilot study aimed at assessing the efficacy and safety of the ClearSkin Module in treating subjects with facial acne scars.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06102343
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acne Scars - Mixed Atrophic and Hypertrophic
Currently open trials in the same condition.
- NCT06868615 — AVAVA MIRIA General Use · NA · recruiting
- NCT06557434 — AV-23-001 AVAVA MIRIA Pilot Study · NA · active not recruiting
- NCT05597267 — The MIRIA Acne Scar Study · NA · active not recruiting
Other Alma Lasers trials
Trials by the same sponsor.
- NCT05016674 — Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat · NA · withdrawn
- NCT04640207 — The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment · NA · completed
- NCT04599751 — The Trio Laser Module for Hair Removal Treatment · NA · completed
- NCT04153071 — Unipolar Microplasma Radiofrequency Device: In-vivo Histologic Study · NA · withdrawn
- NCT03800563 — Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06102343 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alma Lasers
- Last refreshed: 26 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06102343.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing